Neoantigens: are antigens encoded by tumor-specific mutated genes. Studies in the past few years have suggested a key role for neoantigens in cancer immunotherapy.
Neoantigen based personalized immuno-oncology drugs are a relatively new therapeutic avenue that have shown strong anti-tumor efficacy in the clinic. Neoantigen peptides have been widely rep...
NCI estimates that cancer will be the leading cause of death in 2030, worldwide. Checkpoint inhibitors and adoptive cell therapies (ACTs) cost up to ~$2 million/patient and have shown durabl...
Tumor mutational burden (TMB) is an emerging biomarker that correlates with response to immunotherapeutic agents, such as checkpoint inhibitors. Recent studies indicate that a high mutation l...
Vaccibody has developed a unique platform technology able to substantially potentiate vaccines by an inherent mechanism that attract, activate and deliver antigens to antigen presenting cells...
Neoantigen based personalized immuno-oncology drugs are a relatively new therapeutic avenue that have shown strong anti-tumor efficacy in the clinic. Neoantigen peptides have been widely rep...
NCI estimates that cancer will be the leading cause of death in 2030, worldwide. Checkpoint inhibitors and adoptive cell therapies (ACTs) cost up to ~$2 million/patient and have shown durabl...
Tumor mutational burden (TMB) is an emerging biomarker that correlates with response to immunotherapeutic agents, such as checkpoint inhibitors. Recent studies indicate that a high mutation l...
Vaccibody has developed a unique platform technology able to substantially potentiate vaccines by an inherent mechanism that attract, activate and deliver antigens to antigen presenting cells...
The Power of Omics is a three-day Thermo Fisher Scientific virtual event that focuses on harnessing the power of omics to advance scientific research. The virtual event will feature a series...
Please join us at the 9th Annual Fluidigm Mass Cytometry Virtual Summit This yearly international meeting of the mass cytometry community is designed for new and experienced users, as well a...
Fluidigm Infectious Disease and Oncology Virtual Summit Fluidigm technologies are integral to supporting current progress in cancer, immunology and infectious disease research. Fluidigm has...
Luminex's xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology uses color-coded microspheres as the substrate...
Despite the rapid pace of scientific advances that garner a better understanding of a myriad of diseased on their molecular level, modern drug discovery is a long, complex process. While on t...
The Power of Omics is a three-day Thermo Fisher Scientific virtual event that focuses on harnessing the power of omics to advance scientific research. The virtual event will feature a series...
Please join us at the 9th Annual Fluidigm Mass Cytometry Virtual Summit This yearly international meeting of the mass cytometry community is designed for new and experienced users, as well a...
Fluidigm Infectious Disease and Oncology Virtual Summit Fluidigm technologies are integral to supporting current progress in cancer, immunology and infectious disease research. Fluidigm has...
Luminex's xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology uses color-coded microspheres as the substrate...
Despite the rapid pace of scientific advances that garner a better understanding of a myriad of diseased on their molecular level, modern drug discovery is a long, complex process. While on t...